Home / Media Center / News / TRINITY LIFE SCIENCES ACQUIRES VANCERY’S CUSTOMER RESEARCH TECHNOLOGY
Asset Acquisition Enables Trinity to Better Connect with Healthcare Professionals
Waltham, MA, August 4, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced it signed an asset purchase agreement for the acquisition of Vancery’s customer research technology. The investment expands Trinity’s insights and analytics product offerings, allowing the company to better connect with healthcare professionals to inform commercial strategy for its clients. The new technology will improve primary market research in the life sciences by integrating advanced research methods with an enhanced respondent experience to drive higher quality insights.
“We are thrilled to bring the sophisticated customer research technology that Vancery built to the healthcare space,” said Aparna Deshpande, PhD, Senior Partner, Insights. “Now, more than ever, payer, patient and healthcare provider research are critical in making sure treatments are available ASAP to those in need.”
Besides the technology acquisition, a team of experts from Vancery will join Trinity to continue to support and transform the software for use in healthcare.
“I am so proud of what the Vancery team has built and delighted that Trinity will bring our technology and vision to the next level,” said Gunnar Gregory, CEO, Vancery. “With Trinity, our unique technologies will help incorporate qualitative and quantitative research into their life science clients’ daily decision-making.”
About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With over 25 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity revolutionizing the commercial model, visit trinitylifesciences.com.
Media Contact:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com
Sign up for the latest intelligence
By signing up, you are agreeing to our Privacy Policy.
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.